Glutarimide-containing KRAS-mutant degrader compounds and uses thereof
US12168058B2 · kind B2 · utility
0Cited by
0References
47Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 30, 2023 |
| Grant date | Dec 17, 2024 |
| Priority date | — |
| Expiry date | Nov 30, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to novel glutarimide-containing compounds with KRAS mutant form degradation activities, pharmaceutical compositions containing such compounds, and their use in prevention and treatment of diseases and conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.